Indigestion follows €433m Arkema sale

14 Mar 2012

Groupe Bruxelles Lambert sold its entire 10.01% stake in French chemicals firm Arkema on Wednesday following a strong run in the stock price over the last six months and since the company reported results last week. It traded weakly following the tightly-priced deal, but bankers and analysts away from the deal remain bullish on the stock and expect the indigestion to clear soon.

The seller, advised by Rothschild & Cie, mandated Bank of America Merrill Lynch and HSBC following an auction and they launched an accelerated bookbuild for the up-to 6.2m share sale at around 6.45pm GMT. Price guidance was given at €69.90 to market, a discount of up to 3.73% ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Oops, something went wrong

We're sorry but at the moment we can't load this data